Drug Substance
(Section S)
Chemistry, Manufacturing and Controls (CMC)
Our CMC services are primarily for drug substances of synthetic or semi-synthetic origin and include the Chemistry and Manufacturing (CM) part only. Additionally CMC is required for applications for new dosage forms, new strengths, and other changes to authorized products which require the filing of a supplementary application/submission. CMC services for Biological/ Biotechnological drugs are provided on a case to case basis.
CM services are provided for new active pharmaceutical ingredients (APIs), existing APIs and their corresponding drug products. Our clients may choose to hire us for any one or wholesome of the following list of services.
- Drug Substance
- Master Files (MFs)
- Certificates of Suitability to the Monographs of the European Pharmacopoeia (CEPs)
- General Information
- Nomenclature
- Structure
- General Properties
- Manufacture
- Description of Manufacturing Process and Process Controls
- Control of Materials
- Controls of Critical Steps and Intermediates
- Process Validation and/or Evaluation
- Manufacturing Process Development
- Characterisation
- Elucidation of Structure and other Characteristics
- Impurities
- Control of the Drug Substance
- Specification
- Analytical Procedures
- Validation of Analytical Procedures
- Batch Analyses
- Justification of Specification
- Reference Standards or Materials
- Container Closure System
- Stability
- Stability Summary and Conclusions
- Post-approval Stability Protocol and Stability Commitment
- Stability Data
Drug Product
(Section P)
- Drug Product
- Description and Composition of the Drug Product
- Pharmaceutical Development
- Components of the Drug Product
- Drug Product
- Manufacturing Process Development
- Container Closure System
- Microbiological Attributes
- Compatibility
- Manufacture
- Manufacturer(s)
- Batch Formula
- Description of Manufacturing Process and Process Controls
- Controls of Critical Steps and Intermediates
- Process Validation and/or Evaluation
- Control of Excipients
- Specifications
- Analytical Procedures
- Validation of Analytical Procedures
- Justification of Specifications
- Excipients of Human or Animal Origin
- Novel Excipients
- Control of Drug Product
- Specification(s)
- Analytical Procedures
- Validation of Analytical Procedures
- Batch Analyses
- Characterisation of Impurities
- Justification of Specification(s)
- Reference Standards or Materials
- Container Closure System
- Stability
- Stability Summary and Conclusions
- Post-approval Stability Protocol and Stability Commitment
- Stability Data